406 related articles for article (PubMed ID: 9634197)
1. The regulation of phenotype and function of human liver CD3+/CD56+ lymphocytes, and cells that also co-express CD8 by IL-2, IL-12 and anti-CD3 monoclonal antibody.
Jin Y; Fuller L; Carreno M; Esquenazi V; Tzakis AG; Miller J
Hum Immunol; 1998 Jun; 59(6):352-62. PubMed ID: 9634197
[TBL] [Abstract][Full Text] [Related]
2. A bispecific single-chain antibody directed against EpCAM/CD3 in combination with the cytokines interferon alpha and interleukin-2 efficiently retargets T and CD3+CD56+ natural-killer-like T lymphocytes to EpCAM-expressing tumor cells.
Flieger D; Kufer P; Beier I; Sauerbruch T; Schmidt-Wolf IG
Cancer Immunol Immunother; 2000 Oct; 49(8):441-8. PubMed ID: 11043851
[TBL] [Abstract][Full Text] [Related]
3. Systematic characterization of human CD8+ T cells with natural killer cell markers in comparison with natural killer cells and normal CD8+ T cells.
Ohkawa T; Seki S; Dobashi H; Koike Y; Habu Y; Ami K; Hiraide H; Sekine I
Immunology; 2001 Jul; 103(3):281-90. PubMed ID: 11454057
[TBL] [Abstract][Full Text] [Related]
4. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil].
Chi PD; Li L; Fan YY; Wu CY
Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537
[TBL] [Abstract][Full Text] [Related]
5. The immune reactivity role of HCV-induced liver infiltrating lymphocytes in hepatocellular damage.
Jin Y; Fuller L; Carreno M; Zucker K; Roth D; Esquenazi V; Karatzas T; Swanson SJ; Tzakis AG; Miller J
J Clin Immunol; 1997 Mar; 17(2):140-53. PubMed ID: 9083890
[TBL] [Abstract][Full Text] [Related]
6. Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice.
Hoyle C; Bangs CD; Chang P; Kamel O; Mehta B; Negrin RS
Blood; 1998 Nov; 92(9):3318-27. PubMed ID: 9787169
[TBL] [Abstract][Full Text] [Related]
7. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18.
Ami K; Ohkawa T; Koike Y; Sato K; Habu Y; Iwai T; Seki S; Hiraide H
Clin Exp Immunol; 2002 Jun; 128(3):453-9. PubMed ID: 12109440
[TBL] [Abstract][Full Text] [Related]
8. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15.
Dunne J; Lynch S; O'Farrelly C; Todryk S; Hegarty JE; Feighery C; Doherty DG
J Immunol; 2001 Sep; 167(6):3129-38. PubMed ID: 11544298
[TBL] [Abstract][Full Text] [Related]
9. Synergistic effects of IL-7 and IL-12 on human T cell activation.
Mehrotra PT; Grant AJ; Siegel JP
J Immunol; 1995 May; 154(10):5093-102. PubMed ID: 7730615
[TBL] [Abstract][Full Text] [Related]
10. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
[TBL] [Abstract][Full Text] [Related]
11. [Thymoglobulin efficiently expands cytokine-induced killer cells in a clinical-grade culture protocol].
Chen W; Lin D; Jiang Z; Yang Z; Song S; Zhou J; Zhou L; Sun Y; Yu H; Ma D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):681-5, 690. PubMed ID: 25001928
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-12 amplifies the M. leprae hsp65-cytotoxic response in the presence of tumour necrosis factor-alpha and interferon-gamma generating CD56+ effector cells: interleukin-4 downregulates this effect.
Aleman M; De La Barrera S; Fink S; Finiasz M; Farina MH; Pizzariello G; Sasiain MD
Scand J Immunol; 2000 Mar; 51(3):262-70. PubMed ID: 10736095
[TBL] [Abstract][Full Text] [Related]
13. A new method for in vitro expansion of cytotoxic human CD3-CD56+ natural killer cells.
Carlens S; Gilljam M; Chambers BJ; Aschan J; Guven H; Ljunggren HG; Christensson B; Dilber MS
Hum Immunol; 2001 Oct; 62(10):1092-8. PubMed ID: 11600215
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide stimulates the proliferation of human CD56+CD3- NK cells: a regulatory role of monocytes and IL-10.
Goodier MR; Londei M
J Immunol; 2000 Jul; 165(1):139-47. PubMed ID: 10861046
[TBL] [Abstract][Full Text] [Related]
15. Activation-induced expression of CD56 by T cells is associated with a reprogramming of cytolytic activity and cytokine secretion profile in vitro.
Kelly-Rogers J; Madrigal-Estebas L; O'Connor T; Doherty DG
Hum Immunol; 2006 Nov; 67(11):863-73. PubMed ID: 17145366
[TBL] [Abstract][Full Text] [Related]
16. Immune modulation in cancer patients after adoptive transfer of anti-CD3/anti-CD28-costimulated T cells-phase I clinical trial.
Lum LG; LeFever AV; Treisman JS; Garlie NK; Hanson JP
J Immunother; 2001; 24(5):408-19. PubMed ID: 11696696
[TBL] [Abstract][Full Text] [Related]
17. CD3+CD56+CD8+ cells demonstrating a suppressor T cell-like function in the peripheral blood of colon cancer patients.
Akagi J; Takai E; Tamori Y; Ogawa M
Int J Oncol; 2001 Sep; 19(3):561-6. PubMed ID: 11494036
[TBL] [Abstract][Full Text] [Related]
18. In vivo administration of anti-murine CD3 monoclonal antibody induces selective, long-term anergy in CD8+ T cells.
Woodle ES; Hussein S; Bluestone JA
Transplantation; 1996 Mar; 61(5):798-803. PubMed ID: 8607186
[TBL] [Abstract][Full Text] [Related]
19. Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.
Van den Hove LE; Van Gool SW; Van Poppel H; Baert L; Coorevits L; Van Damme B; Ceuppens JL
Clin Exp Immunol; 1997 Sep; 109(3):501-9. PubMed ID: 9328129
[TBL] [Abstract][Full Text] [Related]
20. Functional characterization of skin-infiltrating lymphocytes in atopic dermatitis.
Reinhold U; Kukel S; Goeden B; Neumann U; Kreysel HW
Clin Exp Immunol; 1991 Dec; 86(3):444-8. PubMed ID: 1721013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
